xcellbio

Check out this mini interview where xcellbio's Yelena Bronevetsky, PhD and Hannah W. Song of The National Institutes of Health chat about hypoxic cell culture for CAR-T cell manufacturing! #celltherapy #carttherapy #nih #cellmanufacturing #xcellbio #cellandgenetherapy

Hadia has been working with Cytek Biosciences to develop some amazing new data showcasing just how much potency and cell fitness can be gained from manufacturing in the #AVATARFoundry. Check it out! #cartcellmanufacturing #celltherapy #cellpotency #cellfitness

Curious what xcellbio is up to? Check out this rundown Senior Scientist Evan gives about his work and the increased potency of CAR T cells manufactured in the #AVATARFoundry! Want to learn more about implementing our technology in your lab? Check out xcellbio.com #transduction #cellexpansion #cellkilling #cartcelltherapy #celltherapy #cellmanufacturing

Curious what xcellbio is up to? Check out this rundown Senior Scientist Evan gives about his work and the increased potency of CAR T cells manufactured in the #AVATARFoundry! Want to learn more about implementing our technology in your lab? Check out xcellbio.com #transduction #cellexpansion #cellkilling #cartcelltherapy #celltherapy #cellmanufacturing

Join Us TOMORROW for a Groundbreaking Webinar! Developing Predictive Cancer Models and More Persistent CAR T-cell Therapies through Enhanced Metabolic Fitness Xcellbio’s James Lim and Brian Feth will be discussing the cutting-edge advancements in CAR T-cell therapies which are aimed at overcoming key challenges in treating solid tumors. December 11, 2024 | 1pm EST There's still time to register! To learn more about xcellbio's talk with Labcorp visit the Xtalks website here. To register, follow this link 👇 https://buff.ly/3UOPspS #Collaboration #CellTherapy #SolidTumors #potency #CarTcell

Join Labcorp and Xcell Biosciences in our upcoming webinar as we address key challenges in cell therapy development for solid tumors, which make up 90% of adult cancers. Learn how using the AVATAR Odyssey system to simulate tumor-like conditions can boost CAR T-cell metabolic fitness, enhance persistence, and improve anti-tumor activity. Register for the webinar: https://lnkd.in/exsCw6u5 #CellTherapy #AVATARSystem #CART #CARTCellTherapy #TME #TumorMicroEnvironment #SolidTumor

Why can't we manufacture cell therapies at scale yet? Here are 3 key challenges and how we can overcome them: Labour Challenges: Skilled operators are scarce, labour is costly, and human involvement introduces variability and potential errors. Solution: Advanced automation can reduce reliance on manual processes, ensuring consistency and quality. Flexibility vs. Automation: Automation often limits flexibility, but each therapy step requires the best tools for therapeutic efficacy. Solution: Future-ready automation systems must allow therapy developers to integrate their preferred tools at every stage. Reliability Concerns: Single points of failure in automated systems can risk the ability to deliver one or more life-saving therapies. Solution: Redundant architectures can ensure robust operation, even if a component, like a robot, fails. Scaling cell therapy manufacturing demands collaborative, innovative partnerships. Together, we can build solutions that ensure safe, efficient, and flexible manufacturing processes. Read more about de-risking cell therapy manufacturing in our white paper. Link in comments. Fresenius Kabi MedTech Europe STÄUBLI Robotics Thermo Fisher Scientific Cell and Gene Therapy Catapult ScaleReady MaxCyte, Inc. NVIDIA 3P innovation Limited xcellbio Autolomous Cellular Highways Azenta Life Sciences Aglaris Ltd Group BioLife Solutions, Inc.

🤝 Collaboration in Action: Advancing CAR T-Cell Therapy for Solid Tumors 🌟 Labcorp and Xcell Biosciences are teaming up to tackle one of the toughest challenges in oncology—solid tumors, which represent 90% of adult cancers. 📢 Join us for a groundbreaking webinar where science meets innovation: 🤝 Explore how our collaborative efforts are using the AVATAR Odyssey system to simulate tumor-like conditions and boost CAR T-cell performance. 🧬 Learn how metabolic reprogramming enhances persistence and anti-tumor activity, driving progress in solid tumor treatments. 📊 Gain data-driven insights into how this partnership is shaping the future of CAR T-cell therapies. 💻 Together, we're unlocking new possibilities in cell and gene therapy. 📅 Register now: https://buff.ly/3UOPspS #Collaboration #CellTherapy #SolidTumors #potency  #CarTcell Labcorp xcellbio

Your cell incubator probably wasn't manufactured in 1917, but that doesn't mean you're not losing out on the potential unlocked by the AVATAR Odyssey. Proudly manufactured in San Francisco, California, the AVATAR Odyssey uses the HYPERPRESS™️ incubation technology to control hyperbaric pressure and oxygen levels to replicate in vivo conditions, including the tumor microenvironment. Maintaining your cells under physiological conditions leads to better science. Visit us at xcellbio.com to learn more #xcellbio #avatarai #curecancer #avatarfoundry #avatarodyssey #enhancepotency #cellandgenetherapy #tumormicroenvironment #celltherapymanufacturing Image credit: Nathan Rock, Industrial Artifacts

Unlocking the Future of CAR T-Cell Therapy for Solid Tumors 🌟 💡 Did you know? Solid tumors account for 90% of adult cancers, presenting significant challenges for CAR T-cell therapies. 📢 Join Labcorp and Xcell Biosciences for an insightful webinar exploring innovative solutions: 🧬 Boost CAR T-cell metabolic fitness using the AVATAR Odyssey system to simulate tumor-like conditions. 🔋 Discover strategies to enhance persistence and anti-tumor activity in CAR T-cell populations. 📊 Gain exclusive insights into how metabolic reprogramming is paving the way for more effective treatments. 💻 Don't miss this opportunity to explore the next frontier in cell and gene therapy. 📅 Register now: https://buff.ly/3UOPspS #CellTherapy #SolidTumors #CellTherapy #Innovation #CarTCells #potency Labcorp xcellbio